| 2021-06-02 | HRUSOVSKY E KEVIN | Chairman, President & CEO | Sell | 6,354 | $48.77 | $309,895.96 | -0.3% | → |
| 2021-06-01 | Fry John J | General Counsel & Secretary | Sell | 226 | $48.32 | $10,919.89 | -0.7% | → |
| 2021-06-01 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 243 | $48.32 | $11,741.30 | -0.7% | → |
| 2021-06-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 153 | $48.32 | $7,392.67 | -0.6% | → |
| 2021-05-28 | Duffy David C. | SVP R&D and CTO | Sell | 1,667 | $51.00 | $85,017.00 | -4.6% | → |
| 2021-05-13 | HRUSOVSKY E KEVIN | Chairman, President & CEO | Sell | 5,000 | $46.30 | $231,491.03 | -0.2% | → |
| 2021-05-03 | HRUSOVSKY E KEVIN | Chairman, President & CEO | Sell | 5,789 | $58.21 | $336,952.06 | - | → |
| 2021-05-03 | Chaubal Amol | Chief Financial Officer | Sell | 178 | $57.86 | $10,298.84 | -0.1% | → |
| 2021-05-03 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 234 | $57.86 | $13,538.26 | -0.2% | → |
| 2021-05-03 | Fry John J | General Counsel & Secretary | Sell | 217 | $57.87 | $12,556.91 | -0.2% | → |
| 2021-05-03 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 147 | $57.85 | $8,504.68 | -0.2% | → |
| 2021-04-20 | HRUSOVSKY E KEVIN | Chairman, President & CEO | Sell | 5,000 | $58.23 | $291,141.94 | -0.3% | → |
| 2021-04-15 | Duffy David C. | SVP R&D and CTO | Sell | 1,667 | $62.14 | $103,587.38 | -4.4% | → |
| 2021-04-08 | HRUSOVSKY E KEVIN | Chairman, President & CEO | Sell | 5,000 | $65.54 | $327,703.10 | -0.3% | → |
| 2021-04-01 | Fry John J | General Counsel & Secretary | Sell | 201 | $62.52 | $12,565.57 | -0.2% | → |
| 2021-04-01 | HRUSOVSKY E KEVIN | Chairman, President & CEO | Sell | 3,432 | $62.52 | $214,555.43 | -0.1% | → |
| 2021-04-01 | Roskey Mark T. | SVP, Strategic Partnerships | Sell | 136 | $62.51 | $8,501.67 | -0.2% | → |
| 2021-04-01 | Mattoon Dawn | Sr. VP, Diagnostics | Sell | 151 | $62.77 | $9,478.04 | -0.2% | → |